Non-motor symptoms (depressive symptoms) of Parkinson's disease and their course under pramipexole treatment
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2014
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 05 Mar 2010 Actual patient number (286) added as reported by ClinicalTrials.gov.
- 15 Jul 2008 The expected completion date for this trial has been extended from Dec 2008 to Apr 2008 as reported by ClinicalTrials.gov.
- 15 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.